English

IMUNON, INC.

EDGAR

CLSN Current report (8-K) · filed 2026-10-27

176 filing records in this dataset, filed from 1996-09-04 to 2026-10-27. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

125 thousand USD

2022 Q4 · USD

Exact inputs and evidence

Revenue: 500000 USD Source
Revenue: 375000 USD Source

Operating margin

-5,541.4%

2022 Q4 · %

Exact inputs and evidence

Operating Income: -24921565 USD Source
Operating Income: -17994814 USD Source
Revenue: 500000 USD Source
Revenue: 375000 USD Source

Operating cash flow

-5.01 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -23096895 USD Source
Operating Cash Flow: -18089337 USD Source

Free cash flow

-5.05 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -23096895 USD Source
Operating Cash Flow: -18089337 USD Source
Capital Expenditure: 267800 USD Source
Capital Expenditure: 222891 USD Source

Cash and cash equivalents: 6.86 million USD 2026-06-30 Source
Exact value

6864378 USD
Long-term debt including current maturities: 6.08 million USD 2023-03-31 Source
Exact value

6080413 USD
Shares outstanding: 4.67 million shares 2026-06-30 Source
Exact value

4665660 shares

Reported share-count change

171.65% · 2.95 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1717500 shares · 2025-06-30· Source
4665660 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

500 thousand USD

2022-01-01 – 2022-12-31

Exact inputs and evidence

Revenue: 125000 USD · 2022-01-01 – 2022-03-31 Source
Revenue: 125000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 125000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 500000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 375000 USD · 2022-01-01 – 2022-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2022-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2022-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 4.13 million

Prior period

−USD 18.62 million

2024-01-01 – 2024-12-31
Current period

−USD 14.5 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-14495028 − -18620242 = 4125214 USD

-18620242 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-14495028 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Year-over-year change in Net income: 4125214 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14495028 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1584065 Filing: 000149315226013850 Input fundies:NetIncome: -18620242 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1382771 Filing: 000149315226013850
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 4.95 million

Prior period

−USD 18.85 million

2024-01-01 – 2024-12-31
Current period

−USD 13.9 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13900000 − -18854970 = 4954970 USD

-18854970 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13900000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Year-over-year change in Operating cash flow: 4954970 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1466460 Filing: 000149315226013850 Input fundies:OperatingCashFlow: -18854970 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1297806 Filing: 000149315226013850
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+849.8%

Prior period

USD 29,541

2024-01-01 – 2024-12-31
Current period

USD 280,572

2025-01-01 – 2025-12-31

Exact inputs and evidence

280572 − 29541 = 251031 USD

29541 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
280572 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Year-over-year change in Capital expenditure: 251031 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 280572 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301121 Filing: 000149315226013850 Input fundies:CapitalExpenditure: 29541 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301583 Filing: 000149315226013850
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 500,000 100% of revenue
Operating costs Derived USD 25.42 million 5,084% of revenue
Operating income −USD 24.92 million −4,984% of revenue
Tax, interest and other Derived USD 10.98 million 2,195% of revenue
Net income −USD 35.9 million −7,180% of revenue

Cash

Operating cash flow −USD 23.1 million −4,619% of revenue
Capital expenditure USD 267,800 54% of revenue
Free cash flow Derived −USD 23.36 million −4,673% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 3,794% of revenue.
2018 Operating loss: operating costs were 4,313% of revenue.
2019 Operating loss: operating costs were 4,213% of revenue.
2020 Operating loss: operating costs were 3,797% of revenue.
2021 Operating loss: operating costs were 4,301% of revenue.
2022 Operating loss: operating costs were 5,084% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	500000	18968432 Derived	-18468432	1933744 Derived	-20402176	-16680705 Derived	Source 2017-01-01 – 2017-12-31: 500000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -18468432 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -20402176 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -16642076 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 38629 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	500000	21565044 Derived	-21065044	-9181685 Derived	-11883359	-7180085 Derived	Source 2018-01-01 – 2018-12-31: 500000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -21065044 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -11883359 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -7041686 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 138399 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	500000	21065473 Derived	-20565473	-3713940 Derived	-16851533	-20608140 Derived	Source 2019-01-01 – 2019-12-31: 500000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -20565473 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -16851533 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -20258982 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 349158 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	500000	18986412 Derived	-18486412	2997149 Derived	-21483561	-15637768 Derived	Source 2020-01-01 – 2020-12-31: 500000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -18486412 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -21483561 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -15618676 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 19092 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	500000	21507190 Derived	-21007190	-237940 Derived	-20769250	-16535216 Derived	Source 2021-01-01 – 2021-12-31: 500000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -21007190 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -20769250 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -16223603 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 311613 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	500000	25421565 Derived	-24921565	10976669 Derived	-35898234	-23364695 Derived	Source 2022-01-01 – 2022-12-31: 500000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -24921565 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -35898234 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -23096895 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 267800 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 500K 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	500000	Revenue: 500000 Open source
20182018-12-31	Revenue	500000	Revenue: 500000 Open source
20192019-12-31	Revenue	500000	Revenue: 500000 Open source
20202020-12-31	Revenue	500000	Revenue: 500000 Open source
20212021-12-31	Revenue	500000	Revenue: 500000 Open source
20222022-12-31	Revenue	500000	Revenue: 500000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 500000 Open source
20182018-12-31	Year over year	0%	Revenue: 500000 Open source Revenue: 500000 Open source
20192019-12-31	Year over year	0%	Revenue: 500000 Open source Revenue: 500000 Open source
20202020-12-31	Year over year	0%	Revenue: 500000 Open source Revenue: 500000 Open source
20212021-12-31	Year over year	0%	Revenue: 500000 Open source Revenue: 500000 Open source
20222022-12-31	Year over year	0%	Revenue: 500000 Open source Revenue: 500000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4,984.3% 2022

Net margin -7,179.6% 2022

Free cash flow margin -4,672.9% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-3,693.7%	Operating Income: -18468432 Open source Revenue: 500000 Open source
20182018-12-31	Operating margin	-4,213%	Operating Income: -21065044 Open source Revenue: 500000 Open source
20192019-12-31	Operating margin	-4,113.1%	Operating Income: -20565473 Open source Revenue: 500000 Open source
20202020-12-31	Operating margin	-3,697.3%	Operating Income: -18486412 Open source Revenue: 500000 Open source
20212021-12-31	Operating margin	-4,201.4%	Operating Income: -21007190 Open source Revenue: 500000 Open source
20222022-12-31	Operating margin	-4,984.3%	Operating Income: -24921565 Open source Revenue: 500000 Open source
20172017-12-31	Net margin	-4,080.4%	Net Income: -20402176 Open source Revenue: 500000 Open source
20182018-12-31	Net margin	-2,376.7%	Net Income: -11883359 Open source Revenue: 500000 Open source
20192019-12-31	Net margin	-3,370.3%	Net Income: -16851533 Open source Revenue: 500000 Open source
20202020-12-31	Net margin	-4,296.7%	Net Income: -21483561 Open source Revenue: 500000 Open source
20212021-12-31	Net margin	-4,153.9%	Net Income: -20769250 Open source Revenue: 500000 Open source
20222022-12-31	Net margin	-7,179.6%	Net Income: -35898234 Open source Revenue: 500000 Open source
20172017-12-31	Free cash flow margin	-3,336.1%	Revenue: 500000 Open source Operating Cash Flow: -16642076 Open source Capital Expenditure: 38629 Open source
20182018-12-31	Free cash flow margin	-1,436%	Revenue: 500000 Open source Operating Cash Flow: -7041686 Open source Capital Expenditure: 138399 Open source
20192019-12-31	Free cash flow margin	-4,121.6%	Revenue: 500000 Open source Operating Cash Flow: -20258982 Open source Capital Expenditure: 349158 Open source
20202020-12-31	Free cash flow margin	-3,127.6%	Revenue: 500000 Open source Operating Cash Flow: -15618676 Open source Capital Expenditure: 19092 Open source
20212021-12-31	Free cash flow margin	-3,307%	Revenue: 500000 Open source Operating Cash Flow: -16223603 Open source Capital Expenditure: 311613 Open source
20222022-12-31	Free cash flow margin	-4,672.9%	Revenue: 500000 Open source Operating Cash Flow: -23096895 Open source Capital Expenditure: 267800 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -23.1M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-16642076	Operating Cash Flow: -16642076 Open source
20182018-12-31	Operating cash flow	-7041686	Operating Cash Flow: -7041686 Open source
20192019-12-31	Operating cash flow	-20258982	Operating Cash Flow: -20258982 Open source
20202020-12-31	Operating cash flow	-15618676	Operating Cash Flow: -15618676 Open source
20212021-12-31	Operating cash flow	-16223603	Operating Cash Flow: -16223603 Open source
20222022-12-31	Operating cash flow	-23096895	Operating Cash Flow: -23096895 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -23.4M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-16680705	Operating Cash Flow: -16642076 Open source Capital Expenditure: 38629 Open source
20182018-12-31	Free cash flow	-7180085	Operating Cash Flow: -7041686 Open source Capital Expenditure: 138399 Open source
20192019-12-31	Free cash flow	-20608140	Operating Cash Flow: -20258982 Open source Capital Expenditure: 349158 Open source
20202020-12-31	Free cash flow	-15637768	Operating Cash Flow: -15618676 Open source Capital Expenditure: 19092 Open source
20212021-12-31	Free cash flow	-16535216	Operating Cash Flow: -16223603 Open source Capital Expenditure: 311613 Open source
20222022-12-31	Free cash flow	-23364695	Operating Cash Flow: -23096895 Open source Capital Expenditure: 267800 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.3% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	43.8%	Total Liabilities: 20809925 Open source Total Assets: 47514433 Open source
20182018-12-31	Liabilities / assets	55.5%	Total Liabilities: 25994515 Open source Total Assets: 46855587 Open source
20192019-12-31	Liabilities / assets	62%	Total Liabilities: 23719332 Open source Total Assets: 38278367 Open source
20202020-12-31	Liabilities / assets	50.4%	Total Liabilities: 18916257 Open source Total Assets: 37527338 Open source
20212021-12-31	Liabilities / assets	24.6%	Total Liabilities: 18250868 Open source Total Assets: 74046799 Open source
20222022-12-31	Liabilities / assets	33.3%	Total Liabilities: 14648028 Open source Total Assets: 43975894 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.66× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	3.92×	Current Assets: 24311701 Open source Current Liabilities: 6199690 Open source
20182018-12-31	Current assets / current liabilities	4.61×	Current Assets: 28131143 Open source Current Liabilities: 6106536 Open source
20192019-12-31	Current assets / current liabilities	2.06×	Current Assets: 16235198 Open source Current Liabilities: 7894457 Open source
20202020-12-31	Current assets / current liabilities	2.79×	Current Assets: 18824872 Open source Current Liabilities: 6753455 Open source
20212021-12-31	Current assets / current liabilities	7.67×	Current Assets: 51945624 Open source Current Liabilities: 6769658 Open source
20222022-12-31	Current assets / current liabilities	3.66×	Current Assets: 36779691 Open source Current Liabilities: 10037082 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 22.46 million Exact value Exact value: -22461084 USD 2015-01-01 – 2015-12-31: -22461084 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2015-12-31 IMUNON, INC. (edgar:749647) Net Income: -22461084 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22461084 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000143774916028601/clsn-20151231.xml#167280 Filing: 000143774916028601 The citation records this snapshot. The page link may show a newer release later.	−USD 20.83 million Exact value Exact value: -20830563 USD 2015-01-01 – 2015-12-31: -20830563 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2015-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -20830563 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20830563 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000143774916028601/clsn-20151231.xml#179498 Filing: 000143774916028601 The citation records this snapshot. The page link may show a newer release later.	USD 109,341 Exact value Exact value: 109341 USD 2015-01-01 – 2015-12-31: 109341 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2015-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 109341 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 109341 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000143774916028601/clsn-20151231.xml#181879 Filing: 000143774916028601 The citation records this snapshot. The page link may show a newer release later.	−USD 20.94 million Calculation and evidence -20830563 − 109341 USD Exact free cash flow: -20939904 USD 2015-01-01 – 2015-12-31: -20830563 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 109341 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2015-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -20939904 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20830563 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000143774916028601/clsn-20151231.xml#179498 Filing: 000143774916028601 Input fundies:CapitalExpenditure: 109341 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000143774916028601/clsn-20151231.xml#181879 Filing: 000143774916028601 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 20.4 million Exact value Exact value: -20402176 USD 2017-01-01 – 2017-12-31: -20402176 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2017-12-31 IMUNON, INC. (edgar:749647) Net Income: -20402176 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20402176 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315219004184/clsn-20181231.xml#195292 Filing: 000149315219004184 The citation records this snapshot. The page link may show a newer release later.	−USD 16.64 million Exact value Exact value: -16642076 USD 2017-01-01 – 2017-12-31: -16642076 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2017-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -16642076 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16642076 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315219004184/clsn-20181231.xml#196999 Filing: 000149315219004184 The citation records this snapshot. The page link may show a newer release later.	USD 38,629 Exact value Exact value: 38629 USD 2017-01-01 – 2017-12-31: 38629 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2017-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 38629 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38629 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315219004184/clsn-20181231.xml#203407 Filing: 000149315219004184 The citation records this snapshot. The page link may show a newer release later.	−USD 16.68 million Calculation and evidence -16642076 − 38629 USD Exact free cash flow: -16680705 USD 2017-01-01 – 2017-12-31: -16642076 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 38629 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2017-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -16680705 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16642076 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315219004184/clsn-20181231.xml#196999 Filing: 000149315219004184 Input fundies:CapitalExpenditure: 38629 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315219004184/clsn-20181231.xml#203407 Filing: 000149315219004184 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 11.88 million Exact value Exact value: -11883359 USD 2018-01-01 – 2018-12-31: -11883359 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2018-12-31 IMUNON, INC. (edgar:749647) Net Income: -11883359 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11883359 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315220004717/clsn-20191231.xml#142668 Filing: 000149315220004717 The citation records this snapshot. The page link may show a newer release later.	−USD 7.04 million Exact value Exact value: -7041686 USD 2018-01-01 – 2018-12-31: -7041686 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2018-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -7041686 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7041686 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315220004717/clsn-20191231.xml#468892 Filing: 000149315220004717 The citation records this snapshot. The page link may show a newer release later.	USD 138,399 Exact value Exact value: 138399 USD 2018-01-01 – 2018-12-31: 138399 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2018-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 138399 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 138399 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315220004717/clsn-20191231.xml#470056 Filing: 000149315220004717 The citation records this snapshot. The page link may show a newer release later.	−USD 7.18 million Calculation and evidence -7041686 − 138399 USD Exact free cash flow: -7180085 USD 2018-01-01 – 2018-12-31: -7041686 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 138399 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2018-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -7180085 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7041686 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315220004717/clsn-20191231.xml#468892 Filing: 000149315220004717 Input fundies:CapitalExpenditure: 138399 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315220004717/clsn-20191231.xml#470056 Filing: 000149315220004717 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 16.85 million Exact value Exact value: -16851533 USD 2019-01-01 – 2019-12-31: -16851533 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2019-12-31 IMUNON, INC. (edgar:749647) Net Income: -16851533 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16851533 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315221006382/clsn-20201231.xml#237925 Filing: 000149315221006382 The citation records this snapshot. The page link may show a newer release later.	−USD 20.26 million Exact value Exact value: -20258982 USD 2019-01-01 – 2019-12-31: -20258982 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2019-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -20258982 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20258982 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315221006382/clsn-20201231.xml#271623 Filing: 000149315221006382 The citation records this snapshot. The page link may show a newer release later.	USD 349,158 Exact value Exact value: 349158 USD 2019-01-01 – 2019-12-31: 349158 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2019-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 349158 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 349158 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315221006382/clsn-20201231.xml#270459 Filing: 000149315221006382 The citation records this snapshot. The page link may show a newer release later.	−USD 20.61 million Calculation and evidence -20258982 − 349158 USD Exact free cash flow: -20608140 USD 2019-01-01 – 2019-12-31: -20258982 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 349158 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2019-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -20608140 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20258982 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315221006382/clsn-20201231.xml#271623 Filing: 000149315221006382 Input fundies:CapitalExpenditure: 349158 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315221006382/clsn-20201231.xml#270459 Filing: 000149315221006382 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 21.48 million Exact value Exact value: -21483561 USD 2020-01-01 – 2020-12-31: -21483561 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2020-12-31 IMUNON, INC. (edgar:749647) Net Income: -21483561 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21483561 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315222008277/form10-k.htm#2350939 Filing: 000149315222008277 The citation records this snapshot. The page link may show a newer release later.	−USD 15.62 million Exact value Exact value: -15618676 USD 2020-01-01 – 2020-12-31: -15618676 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2020-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -15618676 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15618676 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315222008277/form10-k.htm#2239082 Filing: 000149315222008277 The citation records this snapshot. The page link may show a newer release later.	USD 19,092 Exact value Exact value: 19092 USD 2020-01-01 – 2020-12-31: 19092 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2020-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 19092 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19092 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315222008277/form10-k.htm#2248757 Filing: 000149315222008277 The citation records this snapshot. The page link may show a newer release later.	−USD 15.64 million Calculation and evidence -15618676 − 19092 USD Exact free cash flow: -15637768 USD 2020-01-01 – 2020-12-31: -15618676 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 19092 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2020-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -15637768 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15618676 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315222008277/form10-k.htm#2239082 Filing: 000149315222008277 Input fundies:CapitalExpenditure: 19092 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315222008277/form10-k.htm#2248757 Filing: 000149315222008277 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 20.77 million Exact value Exact value: -20769250 USD 2021-01-01 – 2021-12-31: -20769250 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2021-12-31 IMUNON, INC. (edgar:749647) Net Income: -20769250 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20769250 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315223009604/form10-k.htm#1378187 Filing: 000149315223009604 The citation records this snapshot. The page link may show a newer release later.	−USD 16.22 million Exact value Exact value: -16223603 USD 2021-01-01 – 2021-12-31: -16223603 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2021-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -16223603 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16223603 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315223009604/form10-k.htm#1237850 Filing: 000149315223009604 The citation records this snapshot. The page link may show a newer release later.	USD 311,613 Exact value Exact value: 311613 USD 2021-01-01 – 2021-12-31: 311613 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2021-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 311613 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 311613 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315223009604/form10-k.htm#1241822 Filing: 000149315223009604 The citation records this snapshot. The page link may show a newer release later.	−USD 16.54 million Calculation and evidence -16223603 − 311613 USD Exact free cash flow: -16535216 USD 2021-01-01 – 2021-12-31: -16223603 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 311613 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2021-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -16535216 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16223603 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315223009604/form10-k.htm#1237850 Filing: 000149315223009604 Input fundies:CapitalExpenditure: 311613 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315223009604/form10-k.htm#1241822 Filing: 000149315223009604 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 35.9 million Exact value Exact value: -35898234 USD 2022-01-01 – 2022-12-31: -35898234 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2022-12-31 IMUNON, INC. (edgar:749647) Net Income: -35898234 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35898234 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/form10-k.htm#1375515 Filing: 000149315224011616 The citation records this snapshot. The page link may show a newer release later.	−USD 23.1 million Exact value Exact value: -23096895 USD 2022-01-01 – 2022-12-31: -23096895 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2022-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -23096895 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23096895 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/form10-k.htm#1283042 Filing: 000149315224011616 The citation records this snapshot. The page link may show a newer release later.	USD 267,800 Exact value Exact value: 267800 USD 2022-01-01 – 2022-12-31: 267800 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2022-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 267800 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 267800 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/form10-k.htm#1287117 Filing: 000149315224011616 The citation records this snapshot. The page link may show a newer release later.	−USD 23.36 million Calculation and evidence -23096895 − 267800 USD Exact free cash flow: -23364695 USD 2022-01-01 – 2022-12-31: -23096895 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 267800 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2022-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -23364695 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23096895 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/form10-k.htm#1283042 Filing: 000149315224011616 Input fundies:CapitalExpenditure: 267800 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315224011616/form10-k.htm#1287117 Filing: 000149315224011616 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 19.51 million Exact value Exact value: -19514977 USD 2023-01-01 – 2023-12-31: -19514977 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2023-12-31 IMUNON, INC. (edgar:749647) Net Income: -19514977 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19514977 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm#1371240 Filing: 000149315225008460 The citation records this snapshot. The page link may show a newer release later.	−USD 19.02 million Exact value Exact value: -19022148 USD 2023-01-01 – 2023-12-31: -19022148 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2023-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -19022148 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19022148 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm#1295425 Filing: 000149315225008460 The citation records this snapshot. The page link may show a newer release later.	USD 451,759 Exact value Exact value: 451759 USD 2023-01-01 – 2023-12-31: 451759 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2023-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 451759 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 451759 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm#1299565 Filing: 000149315225008460 The citation records this snapshot. The page link may show a newer release later.	−USD 19.47 million Calculation and evidence -19022148 − 451759 USD Exact free cash flow: -19473907 USD 2023-01-01 – 2023-12-31: -19022148 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 451759 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2023-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -19473907 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19022148 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm#1295425 Filing: 000149315225008460 Input fundies:CapitalExpenditure: 451759 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm#1299565 Filing: 000149315225008460 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 18.62 million Exact value Exact value: -18620242 USD 2024-01-01 – 2024-12-31: -18620242 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2024-12-31 IMUNON, INC. (edgar:749647) Net Income: -18620242 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18620242 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1382771 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	−USD 18.85 million Exact value Exact value: -18854970 USD 2024-01-01 – 2024-12-31: -18854970 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2024-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -18854970 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18854970 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1297806 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	USD 29,541 Exact value Exact value: 29541 USD 2024-01-01 – 2024-12-31: 29541 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2024-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 29541 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29541 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301583 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	−USD 18.88 million Calculation and evidence -18854970 − 29541 USD Exact free cash flow: -18884511 USD 2024-01-01 – 2024-12-31: -18854970 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 29541 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2024-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -18884511 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18854970 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1297806 Filing: 000149315226013850 Input fundies:CapitalExpenditure: 29541 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301583 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 14.5 million Exact value Exact value: -14495028 USD 2025-01-01 – 2025-12-31: -14495028 USD Inspect Net Income Open source Share or cite Citation for Net Income · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Net Income: -14495028 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14495028 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1584065 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	−USD 13.9 million Exact value Exact value: -13900000 USD 2025-01-01 – 2025-12-31: -13900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Operating Cash Flow: -13900000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1466460 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	USD 280,572 Exact value Exact value: 280572 USD 2025-01-01 – 2025-12-31: 280572 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Capital Expenditure: 280572 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 280572 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301121 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.	−USD 14.18 million Calculation and evidence -13900000 − 280572 USD Exact free cash flow: -14180572 USD 2025-01-01 – 2025-12-31: -13900000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 280572 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IMUNON, INC. · 2025-12-31 IMUNON, INC. (edgar:749647) Free cash flow: -14180572 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:57:40Z Snapshot: 4894ffc2bff9887e82dcf8782c3b145ec2b6e7caadc85d6e4d1bc4bb5b219dc6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/749647?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13900000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1466460 Filing: 000149315226013850 Input fundies:CapitalExpenditure: 280572 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/749647/000149315226013850/form10-k.htm#1301121 Filing: 000149315226013850 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

176 filings · 3,919 latest values · 3,919 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000749647, 749647, CLSN, IMNN, clsn, edgar:749647

Also known as CELSION CORPORATION, CELSION CORP, CELSION CORPORATION, CHEUNG LABORATORIES INC, Celsion CORP, Celsion CORP , Celsion Corp, IMUNON, INC., Imunon, Inc.

IMUNON, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation